BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Eli Lilly and Company
Incyte Corporation
Astellas Pharma Inc
Coherus Oncology, Inc.
InSilico Medicine Hong Kong Limited
University Health Network, Toronto
AstraZeneca
BeiGene
Eli Lilly and Company
National Cancer Institute, Naples
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Imugene Limited
Checkpoint Therapeutics, Inc.
AstraZeneca
Genentech, Inc.
Taiho Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
National Cancer Institute, Naples
European Organisation for Research and Treatment of Cancer - EORTC
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Sun Yat-sen University
Nektar Therapeutics
Pfizer
Eli Lilly and Company
The Netherlands Cancer Institute
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Sun Yat-sen University
AIO-Studien-gGmbH
AbbVie
American College of Radiology Imaging Network
Eli Lilly and Company
China Medical University Hospital
Eli Lilly and Company
University of California, San Diego
Johannes Gutenberg University Mainz
National University Hospital, Singapore
Eli Lilly and Company
The University of Texas Health Science Center, Houston
Amgen
Dong-A University Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Altor BioScience
Memorial Sloan Kettering Cancer Center